FDA Inspection 1223619 — Beijing Sciecure Pharmaceutical Co Ltd
The FDA completed an inspection of Beijing Sciecure Pharmaceutical Co Ltd on Oct 27, 2023 in Shunyi District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 27, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shunyi District (China)